Comments
Indoco Remedies on Friday said the US Food and Drug Administration has cleared the Goa-based sterile manufacturing facility for finished dosages. The US health regulator had inspected the plant in November last year, it added.
The change in the inspection classification status from ‘Official Action Initiated’ to ‘Voluntary Action Initiated’ by the USFDA signifies that the site has come out of the warning letter issued to the site in March 2017, the drug firm said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.